Pascual, Gloria https://orcid.org/0000-0003-3810-6647
Domínguez, Diana
Elosúa-Bayes, Marc https://orcid.org/0000-0002-3742-8161
Beckedorff, Felipe https://orcid.org/0000-0001-6735-6851
Laudanna, Carmelo https://orcid.org/0000-0001-8045-320X
Bigas, Claudia
Douillet, Delphine
Greco, Carolina
Symeonidi, Aikaterini
Hernández, Inmaculada
Gil, Sara Ruiz
Prats, Neus
Bescós, Coro https://orcid.org/0000-0002-3865-3037
Shiekhattar, Ramin
Amit, Moran
Heyn, Holger https://orcid.org/0000-0002-3276-1889
Shilatifard, Ali https://orcid.org/0000-0002-7490-2854
Benitah, Salvador Aznar https://orcid.org/0000-0002-9059-5049
Article History
Received: 3 April 2020
Accepted: 30 September 2021
First Online: 10 November 2021
Competing interests
: S.A.B. is a co-founder and scientific advisor of ONA Therapeutics. The other authors declare no competing interests.